CML Alliance

Digital Pharma: Novartis rebuked for “false and misleading” websites

May 7, 2010
Medical Communications disease awareness campaigns

The FDA has issued Novartis with a stern warning over two websites it sponsors, saying it considers gistalliance.com and cmlalliance.com …

Mixed fortunes for major CROs in Q1

May 7, 2010
Research and Development CRO, Covance, ICON, PPD, Parexel, contact research, contract research, contract research organisation

Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …

Blood clot

Encouraging data for ThromboGenics and BioInvent product

May 7, 2010
BioInvent, Lovenox, ThromboGenics, VTE

An antibody-based drug to prevent blood clots after orthopaedic surgery has shown promising results in phase II. TB-402 is a …

Congress to probe McNeil’s GMP violations

May 7, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The US Food and Drug Administration may take additional regulatory action against Johnson & Johnson subsidiary McNeil Consumer Healthcare over …

EMA appoints Alexis Nolte head of quality

May 7, 2010
Manufacturing and Production EMA, appointment, manufacturing and production

The European Medicines Agency has appointed Alexis Nolte to head up its Quality of Medicines Sector. He was previously principal …

New audiences, new marketing tools

May 6, 2010
Sales and Marketing brand, branding, marketing, marketing ideas

Pharmaceutical industry marketers have for many years focused on turning good products into great brands, developing strong core propositions which …

Congress criticises FDA over contaminated heparin case

May 6, 2010
Manufacturing and Production heparin, manufacturing compliance

The US Food and Drug Administration’s follow-up of the contaminated heparin scandal which surfaced in 2008 has been inadequate, according …

AZ signs tuberculosis drug discovery deal

May 6, 2010
Research and Development AstraZeneca, India, TB, tuberculosis

AstraZeneca and the Global Alliance for TB Drug Development are to collaborate on the discovery and development of drugs to treat tuberculosis.The two …

Abbott’s Mark Kontny joins Patheon

May 6, 2010
Manufacturing and Production Patheon, appointment, manufacturing and production

Patheon has appointed Dr Mark Kontny president of global pharmaceutical development services and chief scientific officer. He joins the contract …

Pfizer and Merck post modest results

May 6, 2010
Sales and Marketing 2010 financials, Merck, Pfizer

The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine.  Both …

Greece’s crisis could hit European prices

May 6, 2010
Sales and Marketing Greece, industry, parallel trade, prices

GlaxoSmithKline’s chief executive Andrew Witty has warned that the economic crisis in Greece could have a knock-on effect across Europe, …

Sanofi signs Indian pain drug development deal

May 5, 2010
Research and Development Glenmark, Sanofi-Aventis, chronic pain, pain therapeutics

Sanofi-Aventis has signed an agreement with Indian firm Glenmark Pharmaceuticals to develop novel agents for the treatment of chronic pain. …

Collaborative cancer drug project targets research efficiency

May 5, 2010
Research and Development Animal testing, Animal tests, Cancer, biomarkers, clinical drug development

A new pharma-academia project being managed by the University of Dundee is setting its sights on improving the effectiveness of …

Blog footer

Digital Pharma: Online medical information influences treatment

May 5, 2010
Medical Communications, Sales and Marketing Datapharm, digital patients, patient information

More than half of health searches in the UK result in treatment or management changes, according to new research by …

Virgo expands med ed team

May 5, 2010
Medical Communications Virgo, appointment, medical communications

Virgo Health has expanded its medical education offering, appointing Katherine Mantell and Adam Pittard. Katherine joins the agency as editorial …

More quality issues dog J&J

May 5, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson’s manufacturing is under the spotlight at the FDA once again for quality issues affecting its products. At …

Oxford BioMedica hopes vaccine first will raise interest

May 5, 2010
Sales and Marketing Dendreon, Oxford BioMedica, Provenge, TroVax

Oxford BioMedica is hoping that the approval of the world’s first immunotherapy cancer vaccine in the US will help it …

BMS on tenterhooks over belatacept future

May 4, 2010
Research and Development BMS, belatacept

Bristol-Myers Squibb has been kept on tenterhooks by US regulator the FDA over the future of its investigational kidney transplant …

Pfizer still at number 1, but Lipitor to slip

May 4, 2010
Sales and Marketing Humira, Lipitor, Pfizer, sales

New research suggests that the pharma world is going to be shaken up over the next few years – although …

Laurence_Debroux

Sanofi’s chief strategic officer to step down

May 4, 2010
Sales and Marketing Sanofi-Aventis, appointment, sales and marketing

Laurence Debroux, chief strategic officer at Sanofi-Aventis, is to leave the company at the end of June. The company said …

The Gateway to Local Adoption Series

Latest content